Filing Details
- Accession Number:
- 0001127602-22-026349
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-23 16:42:19
- Reporting Period:
- 2022-11-22
- Accepted Time:
- 2022-11-23 16:42:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
943819 | Resmed Inc | RMD | Surgical & Medical Instruments & Apparatus (3841) | 980152841 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1825782 | Justin Leong | 9001 Spectrum Center Blvd San Diego CA 92123 | President, Asia Latin America | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Remed Common Stock | Acquisiton | 2022-11-22 | 15,000 | $57.76 | 63,594 | No | 4 | M | Direct | |
Remed Common Stock | Disposition | 2022-11-22 | 3,777 | $229.50 | 59,817 | No | 4 | S | Direct | |
Remed Common Stock | Acquisiton | 2022-11-23 | 6,924 | $0.00 | 66,741 | No | 4 | A | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | A | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Resmed Common Stock | ResMed Common Stock Options | Disposition | 2022-11-22 | 15,000 | $0.00 | 15,000 | $57.76 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-11-16 | 2023-11-16 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $229.42 $229.56. The price reported above reflects the weighted average sale price.
- Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on November 23, 2022, when the compensation committee certified that the performance metrics were met.